Roche Sees Covid-19 Antibody Delivery in First Quarter
This article is for subscribers only.
Roche Holding AG is working hard to rapidly boost supply of Covid-19 antibody treatments and will be able to make its first deliveries in the first quarter of next year, according to Chief Executive Officer Severin Schwan.
U.S. biotech Regeneron Pharmaceuticals Inc. has filed in the U.S. for emergency authorization for an antibody cocktail it’s working on with Roche and that could be granted “very soon,” Schwan said Friday in an interview with Bloomberg Television.